Nicholas FS Watson

2.5k total citations
24 papers, 1.4k citations indexed

About

Nicholas FS Watson is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Nicholas FS Watson has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Immunology and 7 papers in Surgery. Recurrent topics in Nicholas FS Watson's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Nicholas FS Watson is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Nicholas FS Watson collaborates with scholars based in United Kingdom, South Korea and Iran. Nicholas FS Watson's co-authors include J H Scholefield, Lindy G. Durrant, Ian Spendlove, Zahra Madjd, Ian O. Ellis, Ahmad Al‐Attar, Judith M. Ramage, Mohammed Ilyas, John Simpson and Robert A. Eagle and has published in prestigious journals such as Gut, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Nicholas FS Watson

24 papers receiving 1.3k citations

Peers

Nicholas FS Watson
David Z. Chang United States
Petr Škapa Czechia
David L. Bajor United States
Liyun Lai Singapore
Mildred Felder United States
Miranda Payne United Kingdom
Simon Laban Germany
Nicholas FS Watson
Citations per year, relative to Nicholas FS Watson Nicholas FS Watson (= 1×) peers Mahiru Kawano

Countries citing papers authored by Nicholas FS Watson

Since Specialization
Citations

This map shows the geographic impact of Nicholas FS Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas FS Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas FS Watson more than expected).

Fields of papers citing papers by Nicholas FS Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas FS Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas FS Watson. The network helps show where Nicholas FS Watson may publish in the future.

Co-authorship network of co-authors of Nicholas FS Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas FS Watson. A scholar is included among the top collaborators of Nicholas FS Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas FS Watson. Nicholas FS Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, Nicholas FS, et al.. (2012). Anal bulking agents for faecal incontinence. Colorectal Disease. 14(s3). 29–33. 29 indexed citations
2.
Hammond, John, Nicholas FS Watson, Jonathan N. Lund, & J R Barton. (2012). Surgical endoscopy training: the Joint Advisory Group on gastrointestinal endoscopy national review. Frontline Gastroenterology. 4(1). 20–24. 12 indexed citations
3.
Hammond, John, Nicholas FS Watson, Jonathan N. Lund, & J R Barton. (2011). The joint advisory group on gastrointestinal endoscopy national survey of endoscopy training amongst UK-based higher surgical trainees. International Journal of Surgery. 9(7). 524–524. 1 indexed citations
4.
Simpson, John, Ahmad Al‐Attar, Nicholas FS Watson, et al.. (2010). Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer. Gut. 59(7). 926–933. 137 indexed citations
5.
Au‐Yong, Iain, Nicholas FS Watson, Catherine Boereboom, et al.. (2010). Endovascular treatment of a Superior Mesenteric Artery Syndrome variant secondary to traumatic pseudoaneurysm. World Journal of Emergency Surgery. 5(1). 7–7. 4 indexed citations
6.
Boereboom, Catherine, et al.. (2009). Endometriosis presenting as an acute groin swelling: a case report. Cases Journal. 2(1). 6438–6438. 5 indexed citations
7.
Boereboom, Catherine, et al.. (2009). Biological tissue graft for pelvic floor reconstruction after cylindrical abdominoperineal excision of the rectum and anal canal. Techniques in Coloproctology. 13(3). 257–258. 14 indexed citations
8.
Ahmed, Mohamed A., Ahmad Al‐Attar, Nicholas FS Watson, et al.. (2009). CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer. Journal of Clinical Pathology. 62(12). 1117–1122. 36 indexed citations
9.
Ullenhag, Gustav, et al.. (2008). T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55. Clinical Immunology. 128(2). 148–154. 21 indexed citations
10.
Watson, Nicholas FS, et al.. (2008). Bilateral sternoclavicular joint septic arthritis secondary to indwelling central venous catheter: a case report. Journal of Medical Case Reports. 2(1). 131–131. 15 indexed citations
11.
Duncan, Timothy J., Nicholas FS Watson, Ahmad Al‐Attar, J H Scholefield, & Lindy G. Durrant. (2007). The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. World Journal of Surgical Oncology. 5(1). 31–31. 59 indexed citations
12.
Madjd, Zahra, Ian Spendlove, Sarah E. Pinder, et al.. (2007). Upregulation of MICA on high-grade invasive operable breast carcinoma.. PubMed. 7. 17–17. 60 indexed citations
13.
Mukherjee, Abhik, et al.. (2007). Overexpression of FLIPL Is an Independent Marker of Poor Prognosis in Colorectal Cancer Patients. Clinical Cancer Research. 13(17). 5070–5075. 81 indexed citations
14.
Watson, Nicholas FS. (2006). Cytoplasmic expression of p27kip1is associated with a favourable prognosis in colorectal cancer patients. World Journal of Gastroenterology. 12(39). 6299–6299. 9 indexed citations
15.
Ullenhag, Gustav, Ian Spendlove, Nicholas FS Watson, et al.. (2006). A Neoadjuvant/Adjuvant Randomized Trial of Colorectal Cancer Patients Vaccinated with an Anti-Idiotypic Antibody, 105AD7, Mimicking CD55. Clinical Cancer Research. 12(24). 7389–7396. 30 indexed citations
16.
Watson, Nicholas FS, Lindy G. Durrant, Zahra Madjd, et al.. (2005). Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients. Cancer Immunology Immunotherapy. 55(8). 973–980. 59 indexed citations
17.
Watson, Nicholas FS, Zahra Madjd, Ian Spendlove, et al.. (2005). Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: A tissue microarray study of 460 patients. World Journal of Surgical Oncology. 3(1). 47–47. 39 indexed citations
18.
Watson, Nicholas FS, Ian Spendlove, Zahra Madjd, et al.. (2005). Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. International Journal of Cancer. 118(6). 1445–1452. 137 indexed citations
19.
Madjd, Zahra, et al.. (2005). High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Research. 7(5). R780–7. 78 indexed citations
20.
Watson, Nicholas FS, Judith M. Ramage, Zahra Madjd, et al.. (2005). Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. International Journal of Cancer. 118(1). 6–10. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026